These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23359506)

  • 1. Butyrophilin-like 2 modulates B7 costimulation to induce Foxp3 expression and regulatory T cell development in mature T cells.
    Swanson RM; Gavin MA; Escobar SS; Rottman JB; Lipsky BP; Dube S; Li L; Bigler J; Wolfson M; Arnett HA; Viney JL
    J Immunol; 2013 Mar; 190(5):2027-35. PubMed ID: 23359506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
    Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
    J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foxp3+ regulatory T cells are activated in spite of B7-CD28 and CD40-CD40L blockade.
    Vogel I; Verbinnen B; Maes W; Boon L; Van Gool SW; Ceuppens JL
    Eur J Immunol; 2013 Apr; 43(4):1013-23. PubMed ID: 23348953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immature dendritic cells convert anergic nonregulatory T cells into Foxp3- IL-10+ regulatory T cells by engaging CD28 and CTLA-4.
    Pletinckx K; Vaeth M; Schneider T; Beyersdorf N; Hünig T; Berberich-Siebelt F; Lutz MB
    Eur J Immunol; 2015 Feb; 45(2):480-91. PubMed ID: 25382658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costimulation of CD28- T lymphocytes by 4-1BB ligand.
    DeBenedette MA; Shahinian A; Mak TW; Watts TH
    J Immunol; 1997 Jan; 158(2):551-9. PubMed ID: 8992967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B7+ iris pigment epithelial cells convert T cells into CTLA-4+, B7-expressing CD8+ regulatory T cells.
    Sugita S; Keino H; Futagami Y; Takase H; Mochizuki M; Stein-Streilein J; Streilein JW
    Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5376-84. PubMed ID: 17122127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BTNL8, a butyrophilin-like molecule that costimulates the primary immune response.
    Chapoval AI; Smithson G; Brunick L; Mesri M; Boldog FL; Andrew D; Khramtsov NV; Feshchenko EA; Starling GC; Mezes PS
    Mol Immunol; 2013 Dec; 56(4):819-28. PubMed ID: 24036152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C6-ceramide in combination with transforming growth factor-β enhances Treg cell differentiation and stable FoxP3 expression in vitro and in vivo.
    Kue CS; Lim HX; Jung MY; Hong HJ; Cho D; Kim TS
    Immunobiology; 2013 Jul; 218(7):952-9. PubMed ID: 23313049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butyrophilin Btn2a2 inhibits TCR activation and phosphatidylinositol 3-kinase/Akt pathway signaling and induces Foxp3 expression in T lymphocytes.
    Ammann JU; Cooke A; Trowsdale J
    J Immunol; 2013 May; 190(10):5030-6. PubMed ID: 23589618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
    Tao X; Constant S; Jorritsma P; Bottomly K
    J Immunol; 1997 Dec; 159(12):5956-63. PubMed ID: 9550393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4.
    Mandelbrot DA; Oosterwegel MA; Shimizu K; Yamada A; Freeman GJ; Mitchell RN; Sayegh MH; Sharpe AH
    J Clin Invest; 2001 Apr; 107(7):881-7. PubMed ID: 11285307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse Sertoli cells display phenotypical and functional traits of antigen-presenting cells in response to interferon gamma.
    Dal Secco V; Riccioli A; Padula F; Ziparo E; Filippini A
    Biol Reprod; 2008 Feb; 78(2):234-42. PubMed ID: 17989360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of human T cell lymphotropic virus type I-infected T cells is independent of B7 costimulation.
    Scholz C; Freeman GJ; Greenfield EA; Hafler DA; Höllsberg P
    J Immunol; 1996 Oct; 157(7):2932-8. PubMed ID: 8816399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BTNL2, a butyrophilin/B7-like molecule, is a negative costimulatory molecule modulated in intestinal inflammation.
    Arnett HA; Escobar SS; Gonzalez-Suarez E; Budelsky AL; Steffen LA; Boiani N; Zhang M; Siu G; Brewer AW; Viney JL
    J Immunol; 2007 Feb; 178(3):1523-33. PubMed ID: 17237401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated B cells express CD28/B7-independent costimulatory activity.
    Ding L; Shevach EM
    J Immunol; 1996 Aug; 157(4):1389-96. PubMed ID: 8759718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation.
    Sperling AI; Auger JA; Ehst BD; Rulifson IC; Thompson CB; Bluestone JA
    J Immunol; 1996 Nov; 157(9):3909-17. PubMed ID: 8892622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
    Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
    Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutting edge: CD28 and c-Rel-dependent pathways initiate regulatory T cell development.
    Vang KB; Yang J; Pagán AJ; Li LX; Wang J; Green JM; Beg AA; Farrar MA
    J Immunol; 2010 Apr; 184(8):4074-7. PubMed ID: 20228198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.